Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms: A randomized, double-blind, placebo- controlled trial

Archives of General Psychiatry

Volumn 54, Issue 9, 1997, Pages 857-864

  Gillberg, Christopher ^a   Melander, Hans ^e   Von Knorring, Anne Liis ^b   Janols, Lars Olof ^b   Thernlund, Gunilla ^c   Hägglöf, Bruno ^d   Eidevall Wallin, Lena ^c   Gustafsson, Peik ^c   Kopp, Svenny ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d UMEÅ UNIVERSITY   (Sweden)

^e MEDICAL PRODUCTS AGENCY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CENTRAL STIMULANT AGENT; PLACEBO;

ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0030882054     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1997.01830210105014     Document Type: Article

References (34)

1. Bradley C. The behavior of children receiving benzedrine. Am J Psychiatry. 1937; 94:577-585.
2. Jacobvitz D, Sroufe LA, Stewart M, Leffert N. Treatment of additional and hyperactivity problems in children with sympathomimetic drugs: a comprehensive review. J Am Acad Child Adolesc Psychiatry. 1990;29:677-688.
3. Stevenson RD, Wolraich MD. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder. Pediatr Clin North Am. 1989; 36:1183-1197.
4. DuPaul GJ, Barkley RA. Social interaction of children with attention deficit hyperactivity disorder: effects of methylphenidate. In: McCord R, Tremblay RE, eds. Preventing Antisocial Behavior: Interventions From Birth Through Adolescence. New York, NY: Guilford Press; 1992:89-116.
5. Barkley RA. The social interactions of hyperactive children: developmental changes, drug effects and situational variation. In: McMahon R, Peters R, eds. Childhood Disorders: Behavioral-Developmental Approaches. New York, NY: Brunner/ Mazel; 1985:218-243.
6. DuPaul GJ, Barkely RA. Behavioral contributions to pharmacotherapy: the utility of behavioral methodology in medication treatment of children with attention deficit hyperactivity disorder. Behav Ther. 1993;24:47-65.
7. Douglas VI, Barr RG, O'Neill ME, Britton BG. Short-term effects of methylphenidate on the cognitive learning academic performance of children with attention deficit disorder in the laboratory and the classroom. J Child Psychol Psychiatry. 1986;27:191-211.
8. Sebrechts MM, Shaywitz SD, Shaywitz BA, Jatlow P, Anderson GM, Cohen DJ. Components of attention, methylphenidate dosage and blood levels in children with attention deficit disorder. Pediatrics. 1986;77:222-228.
9. Garfinkel BD, Wender PH, Sloman L, O'Neill I. Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children. J Am Acad Child Psychiatry. 1983;22:343-348.
10. Elia J, Borcherding BG, Rapoport JL, Keysor CS. Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders? Psychiatry Res. 1991;36:141-155.
11. Rosenberg DR, Holttum J, Gershon S. Textbook of Pharmacotherapy for Child and Adolescent Psychiatric Disorders. New York, NY: Brunner/Mazel; 1994.
12. Gadow K, Nolan E, Sprafkin J. School observations of children with attention-deficit hyperactivity disorder and comorbid tic disorder: effect of methylphenidate treatment. J Dev Behav Pediatr. 1995;16:167-176.
13. DuPaul GJ, Stoner G. ADHD in the Schools: Assessment and Intervention Strategies. New York, NY: Guilford Press; 1994.
14. Dulcan MK. Using psychostimulants to treat behavioral disorders of children and adolescents. J Child Adolesc Psychopharmacol. 1990;1:7-22.
15. Fulton A, Yates WR. Family abuse of methylphenidate. Am Fam Physician. 1988; 38:143-145.
16. Riddle KD, Rapoport JL. A 2-year follow-up of 72 hyperactive boys. J Nerv Ment Dis. 1976;162:126-134.
17. Weiss G, Kruger E, Danielson U, Elman M. Effect of long-term treatment of hyperactive children with methylphenidate. Can Med Assoc J. 1975;112:159-165.
18. Satterfield JH, Satterfield BT, Cantwell DP. Three-year multimodality treatment study of 100 hyperactive boys. J Pediatrics. 1981;98:143-144.
19. Barkley RA. Hyperactive Children: A Handbook for Diagnosis and Treatment. New York, NY: Guilford Press; 1990.
20. Swedish Medical Products Agency. Medikamentell behandling av uppmärksamhetsstörningar med hyperaktivitet hos barn. Uppsala, Sweden: Swedish Medical Products Agency; 1991;1:7-11.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987.
22. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva, Switzerland: World Health Organization; 1993.
23. Landgren M, Kjellman B, Gillberg C. ADHD, DAMP and other neurodevelopmental/ neuropsychiatric disorders in six-year-old children: epidemiology and comorbidity. Dev Med Child Neurol. 1996;38:891-906.
24. Gillberg IC, Gillberg C, Groth J. Children with preschool minor neurodevelopmental disorders, V: neurodevelopmental profiles at age 13. Dev Med Child Neurol. 1989;31:14-24.
25. Wechsler D. Wechsler Intelligence Scale for Children, Third Edition - Revised. New York, NY: Psychological Corporation; 1992.
26. Conners CK. Conners Rating Scales Manual, Conners Teacher Rating Scales, Conners Parent Rating Scales: Instruments for Use With Children and Adolescents. North Tonawanda, NY: Multihealth Systems; 1990.
27. Birleson P. The validity of depressive disorder in childhood and the development of a self-rating scale: a research report. J Child Psychol Psychiatry. 1981; 22:73-88.
28. McGrath PA, Veber LL, Hearth MT. Multidimensional pain assessment in children. In: Fidds HL, et al, eds. Advances in Pain Research and Therapy. New York, NY: Raven Press; 1985;9:387-393.
29. Klein RG, Mannuzza S. Hyperactive boys almost grown up, III: methylphenidate effects on ultimate height. Arch Gen Psychiatry. 1988;45:1131-1134.
30. Taylor E, Schachar R, Thorley G, Wieselberg HM, Everitt B, Rutter M. Which boys respond to stimulant treatment? a controlled trial of methylphenidate in boys with disruptive behaviour. Psychol Med. 1987;17:121-143.
31. Handen BL, Janosky J, McAuliffe S, Breaux AM, Feldman H. Prediction of response to methylphenidate among children with ADHD and mental retardation. J Am Acad Child Adolesc Psychiatry. 1994;33:1185-1193.
32. Mayes SD, Crites DL, Bixler EO, Humphrey FJ II, Mattison RE. Methylphenidate and ADHD : influence of age, IQ and neurodevelopmental status. Dev Med Child Neurol. 1994;36:1099-1107.
33. Quintana H, Firmaher B, Stedge D, Lennon S, Freed J, Bridge J, Greenhill L. Use of methylphenidate in treatment of children with autistic disorder. J Autism Dev Disord. 1995;25:283-294.
34. Gillberg C, Hellgren L. Outcome of attention disorders. In: Sandberg S, ed. Hyperactivity Disorders. Cambridge, England: Cambridge University Press; 1996: 473-499.